73 related articles for article (PubMed ID: 21761022)
1. Functioning metastasis from adrenocortical carcinoma.
Cunha C; Donato S; Silva T; Leite V
BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35078872
[TBL] [Abstract][Full Text] [Related]
2. The effect of adjuvant mitotane therapy of the adrenocortical carcinoma on the endometrium and its clinical consequences in menstruating women. Literature review and authors' own experiences.
Szkodziak P; Szkodziak F; Korolczuk A; Obel E; Woźniak S; Paszkowski T
Am J Cancer Res; 2024; 14(4):1802-1814. PubMed ID: 38726272
[TBL] [Abstract][Full Text] [Related]
3. Effects of mitotane treatment on human steroid metabolism: implications for patient management.
Ghataore L; Chakraborti I; Aylwin SJ; Schulte KM; Dworakowska D; Coskeran P; Taylor NF
Endocr Connect; 2012 Jul; 1(1):37-47. PubMed ID: 23781302
[TBL] [Abstract][Full Text] [Related]
4. Local advanced adrenocortical cancer with a long-term recurrence-free survival treated with complete surgical excision and adjuvant therapy with a very low-dose mitotane.
Tokura Y; Kobayashi M; Kamai T
IJU Case Rep; 2020 Nov; 3(6):233-235. PubMed ID: 33163911
[TBL] [Abstract][Full Text] [Related]
5. Exogenous steroid replacement in a pediatric patient with adrenocortical carcinoma receiving mitotane.
Martin CE; Kuhn AK; Leopold KN; Creo AL; Schoettler PJ; Allen-Rhoades WA
Pediatr Blood Cancer; 2024 May; ():e31072. PubMed ID: 38736192
[No Abstract] [Full Text] [Related]
6. A Case of Drug Reaction With Eosinophilia and Systemic Symptoms Caused by Mitotane: A Cytotoxic Drug Treating Adrenocortical Carcinoma.
Qi J; Zhang Q; Jiang X
Dermatitis; 2024 Apr; ():. PubMed ID: 38593446
[No Abstract] [Full Text] [Related]
7. Fluorodeoxyglucose (FDG) Uptake in the Remnant Adrenal Gland Mimicking Tumor Recurrence in a Patient With Adrenocortical Carcinoma After Treatment With Mitotane.
Ayala Torres JD; Noreña Rengifo B
Cureus; 2024 Mar; 16(3):e55486. PubMed ID: 38571874
[TBL] [Abstract][Full Text] [Related]
8. Prominent
Al-Rashdan R; Aljaberi M; Mohamedkhair A; Al-Ibraheem A
Asia Ocean J Nucl Med Biol; 2023; 11(2):181-184. PubMed ID: 37324222
[TBL] [Abstract][Full Text] [Related]
9. Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography/computed tomography: a review of literature.
Kandathil A; Wong KK; Wale DJ; Zatelli MC; Maffione AM; Gross MD; Rubello D
Endocrine; 2015 May; 49(1):6-26. PubMed ID: 25273320
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group.
Postlewait LM; Ethun CG; Tran TB; Prescott JD; Pawlik TM; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Staley CA; Poultsides GA; Maithel SK
J Am Coll Surg; 2016 Apr; 222(4):480-90. PubMed ID: 26775162
[TBL] [Abstract][Full Text] [Related]
11. Surgical management of adrenocortical carcinoma.
Ranvier GG; Inabnet WB
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):435-52. PubMed ID: 26038210
[TBL] [Abstract][Full Text] [Related]
12. Mitotane treatment for adrenocortical carcinoma: an overview.
De Francia S; Ardito A; Daffara F; Zaggia B; Germano A; Berruti A; Di Carlo F
Minerva Endocrinol; 2012 Mar; 37(1):9-23. PubMed ID: 22382612
[TBL] [Abstract][Full Text] [Related]
13. High (18)F-FDG uptake by the remaining adrenal gland four months after surgery and initiation of mitotane treatment in two patients with adrenocortical carcinoma.
Mpanaka I; Lyra VD; Kaltsas G; Chatziioannou SN
Hell J Nucl Med; 2011; 14(2):168-72. PubMed ID: 21761022
[TBL] [Abstract][Full Text] [Related]
14. Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancy.
Leboulleux S; Deandreis D; Escourrou C; Al Ghuzlan A; Bidault F; Aupérin A; Travagli JP; Lumbroso J; Schlumberger M; Baudin E
Eur J Endocrinol; 2011 Jan; 164(1):89-94. PubMed ID: 20921280
[TBL] [Abstract][Full Text] [Related]
15. Predicitve Value of FDG Uptake in the Remaining Adrenal Gland Following Adrenalectomy for Adrenocortical Cancer.
Loewe R; Rogowski-Lehmann N; Pfluger T; Reincke M; Hahner S; Bluemel C; Fassnacht M; Beuschlein F
Horm Metab Res; 2021 Jan; 53(1):24-31. PubMed ID: 33086388
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
